US HB6348 | 2015-2016 | 114th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on November 17 2016 - 25% progression, died in committee
Action: 2016-11-17 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on November 17 2016 - 25% progression, died in committee
Action: 2016-11-17 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To extend for two years the program for priority review to encourage treatments for rare pediatric diseases. This bill amends the Federal Food, Drug, and Cosmetic Act to extend through 2018 the priority review voucher program for treatments for rare pediatric diseases. (A priority review voucher is a transferable voucher that entitles the holder to have a new drug or biological product application acted upon by the Food and Drug Administration within six months.)
Title
To extend for two years the program for priority review to encourage treatments for rare pediatric diseases.
Sponsors
| Rep. Alan Grayson [D-FL] |
History
| Date | Chamber | Action |
|---|---|---|
| 2016-11-17 | House | Referred to the House Committee on Energy and Commerce. |
| 2016-11-17 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/114th-congress/house-bill/6348/all-info |
| Text | https://www.congress.gov/114/bills/hr6348/BILLS-114hr6348ih.pdf |
